Viral Inactivation Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

The global Viral Inactivation market size is expected to be worth around US$ 15.1 billion by 2030, according to a new report by Vision Research Reports.

The global Viral Inactivation market size was valued at US$ 11.8  billion in 2020 and is anticipated to grow at a CAGR of 22.5 % during forecast period 2021 to 2030.

Growth Factors

 Rise in the number of pharmaceutical and biopharmaceutical companies, increase in FDA drug approvals, growth of the life sciences industry, increase in government funding for novel therapies, and drug development are some of the major factors contributing to the growth.

Immense growth has been witnessed in the pharmaceutical and biopharmaceutical industry with a steady rise in the number of companies, drug launches, and new drug discoveries. With an increase in the number of diseases worldwide, the need for new & improved drugs and therapies has been witnessed on a global front. Increase in investment by top players in research and development coupled with the need to find new therapies for the treatment of diseases has contributed to immense growth of pharmaceutical and biopharmaceutical companies, thereby accelerating growth.

Report Highlights

Based on the product, the market is categorized into kits & reagents, systems, and services. Kits and reagents accounted for the largest market share in the market due to their continuous usage by pharmaceutical and biopharmaceutical companies. Services are anticipated to grow at the highest rate owing to ease of management and specialized services offered by service providing companies. 

With an increase in the number of pharmaceutical and biopharmaceutical companies and a rise in R&D spending for new drug development, the usage of kits and reagents has increased tremendously. Thus, owing to the increasing utilization of consumables, kits, and reagents in various end-use settings, it was the largest segment concerning the product in the market.

A wide range of instruments aid in the process of viral inactivation. For instance, FlexAct VI developed by Sartorius AG is a single-use technology that allows virus inactivation with the usage of low pH. The device is designed in a way to address the production capacity and tailored to adjust features like pH, pressure, temperature, pump speed, and fluid level.

Virus inactivation is a vital process in the drug manufacturing companies that require sterilization of the media before product finalization. Thus, a wide range of methods is provided as services by many Contract Research Organizations (CROs). All safety and quality standards are maintained at such facilities as they provide efficient virus inactivation and planning of further steps in the drug development process.

Based on application, the viral inactivation market is segmented into vaccines & therapeutics, stem cell products, blood & blood tissue products, tissue & tissue products, and cellular & gene therapy products. Vaccines & therapeutics is expected to grow at the fastest rate due to growth in biologics production and an increase in government funding for the promotion of usage of biologics to treat diseases. Increasing R&D innovation in various other applications such as stem cell research and cellular & gene therapy has also been significantly contributing to the growth of the market. 

Stem cell products are procured from donors and the risk of contamination is high owing to the requirement of intense monitoring concerning viral inactivation. Stem cell research has been increasing rapidly in developed countries like the U.S. and other European countries. This increase has contributed largely to the growth of the segment. Stem cell research has been pursued largely to gain a deeper insight into human health and discover new ways to treat illnesses & diseases.

With a global rise in the number of transplantation procedures, there has been an increase in tissue and tissue products. Since the risk of viral contamination from donors is very high, the need for viral inactivation in these products is tremendous. Most of the time, solvent detergent is a preferred choice of viral inactivation in these instances. Low pH is another method that is used for viral inactivation in blood tissue and tissue products.                           

In most cases, the sources of vaccines and therapeutics are mammalian cell cultures, bacteria, insect cell culture, plant cell culture, mice, humans, avian cell culture, and yeast (in some cases). Inactivation of viruses in these cases is an integral part of safety and assessment procedures, making the intended product safe for human usage. Thus, the growth of the market of viral inactivation has been significant owing to the consistent usage of viral inactivation products in applications, such as cellular & gene therapy, stem cell products, and tissue & tissue products.

Based on end-use, the viral inactivation industry is divided into pharmaceutical and biopharmaceutical companies, CROs, academic & research institutes, and others. Others include medical device companies, laboratories, and blood banks. Pharmaceutical and biopharmaceutical companies accounted for the largest share owing to an increased usage of these products for drug development and drug manufacturing. CROs provide customized services and efficient management of the entire viral inactivation process. Therefore, these are expected to gain considerable share during the forecast period. 

The growth of pharmaceutical and biopharmaceutical companies has been immense over the past few decades. An increase in the amount of investment to find alternative therapies has increased the number of new drugs. With the introduction of biologics and other cellular & gene therapy products, the usage of viral inactivation products has been increasing in pharmaceutical and biopharmaceutical companies.

Stringent regulatory requirements for therapeutic agents ensure the safety of the product, for human use. Usage of techniques like solvent detergent, low pH, pasteurization, and other methods is found commonly in biopharmaceutical companies to ensure the safety of the product. Companies make use of single-use systems or bioreactors to perform these procedures and conduct viral inactivation.

Key Players

Sartorius AG, Merck KGaA, Parker Hannifin, Rad Source Technologies, Clean Cells, WuXi PharmaTech (Cayman) Inc., and Danaher. 

Market Segmentation

The Viral Inactivation market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Viral Inactivation market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Viral Inactivation market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Inactivation market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Viral Inactivation market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Viral Inactivation capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Viral Inactivation by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Viral Inactivation market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Viral Inactivation market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Viral Inactivation market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Viral Inactivation industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Viral Inactivation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Viral Inactivation market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Viral Inactivation market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Viral Inactivation market. These factors have benefited the growth of the global market for Viral Inactivation. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Viral Inactivation. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Viral Inactivation are as follows:

• Historic Year: 2017-2020
• Base Year: 2021
• Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.